scholarly journals A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia

Cancer ◽  
2019 ◽  
Vol 126 (6) ◽  
pp. 1264-1273 ◽  
Author(s):  
Rupa Narayan ◽  
Traci M. Blonquist ◽  
Ashkan Emadi ◽  
Robert P. Hasserjian ◽  
Meghan Burke ◽  
...  
2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 7044-7044 ◽  
Author(s):  
Jorge E. Cortes ◽  
Stefan Faderl ◽  
John Pagel ◽  
Chul Won Jung ◽  
Sung-Soo Yoon ◽  
...  

2018 ◽  
Vol 109 (10) ◽  
pp. 3235-3244 ◽  
Author(s):  
Kensuke Usuki ◽  
Toru Sakura ◽  
Yukio Kobayashi ◽  
Toshihiro Miyamoto ◽  
Hiroatsu Iida ◽  
...  

2018 ◽  
Vol 18 ◽  
pp. S204-S205 ◽  
Author(s):  
Courtney D. DiNardo ◽  
Eytan M. Stein ◽  
Stéphane de Botton ◽  
Gail J. Roboz ◽  
Jessica K. Altman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document